record state
frontier-ownedReview status
This finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
unreviewed
frontiers / frontier
Finding bundle
back to stateno incoming links yet
record state
frontier-ownedThis finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
finding statement
finding typeNo entity list is declared.
evidence
source-boundobservational · manual state transition
proof impact
packet context1 reviewable changes and 0 evaluation records are attached to this finding id.
Evidence and conditions
method
manual state transition
evidence type
observational
evidence spans
Under which specific patient subgroups or disease stages does amyloid-targeting with lecanemab produce measurable clinical benefit?
Lecanemab showed modest but real efficacy in Clarity AD trial.md · curator_source · Lecanemab showed modest but real efficacy in Clarity AD trial.md
conditions
Provenance
source title
Lecanemab showed modest but real efficacy in Clarity AD trial.md
authors
reviewer:will-blair-bot
Under which specific patient subgroups or disease stages does amyloid-targeting with lecanemab produce measurable clinical benefit?
vs_c89133a1e2b42446 · source:Lecanemab showed modest but real efficacy in Clarity AD trial.md|section:curator_source · manual_curation
outgoing
No outgoing links.
incoming
No incoming links.
events
vev_5e25a99b801a3266finding.assertedManual finding added to frontier state
reviewer:will-blair-bot · 2026-05-06
reviewable changes
vpr_f2cafc20a300898afinding.addManual finding added to frontier state
applied · reviewer:will-blair-bot · 2026-05-06
evaluations
No evaluation record targets this finding id.